← Leaderboards
Oliver Voss
University Of Maryland Baltimore
$212,438
Attributed
$424,875
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $231.8K · FY2022–23$250K$187.5K$125K$62.5K$0
'22
'23
Funding mix
By agency
NIH$424,875 · 1
By mechanism
R21$424,875 · 1
Top collaborators
- Mohammed Sayeedur Rahman2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Abdu F Azad$25,191,182
- Mohammed Sayeedur Rahman$3,351,113
- Holly Gaff$2,827,844
- Joseph J Gillespie$1,066,963
- Joao Pedra$16,588,879
Others in their field
Other Rising Stars on “Eating”
- Christine W Hockett · Avera Mckennan$8,908,366
- Lidia Minguez Alarcon · Brigham And Women'S Hospital$4,645,231
- Erik A Willis · Univ Of North Carolina Chapel Hill$3,558,399
- Tobias Janowitz · Cold Spring Harbor Laboratory$3,288,058
- Cody Neshteruk · Duke University$3,145,056
- Simon Vu · Equator Therapeutics, Inc.$3,142,274
Research focus
EatingAnimalsDisease OutbreaksDistantAnti-Inflammatory AgentsAnxa5 GeneApoptoticDichloromethylene DiphosphonateAffinityArthropod-BorneArthropodsArthropod VectorsBacteriaBindingBone MarrowBoutonneuse FeverAntibodiesCellsArhgef5 GeneCell Surface ReceptorsCentral AmericaDendritic CellsDermisEndemic Flea-Borne Typhus
Grant awards (2)
Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis$193,125
R21 · FY2023 · AI · contact PI
Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis$231,750
R21 · FY2022 · AI · contact PI